Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 3.040
-0.080 (-2.56%)
At close: Feb 13, 2026
Hua Medicine (Shanghai) Market Cap
Hua Medicine (Shanghai) has a market cap or net worth of 3 billion as of February 13, 2026. Its market cap has increased by 115.59% in one year.
Market Cap
3.00B
Enterprise Value
2.18B
Revenue
406.16M
Ranking
n/a
PE Ratio
2.54
Stock Price
3.04
Market Cap Chart
Since September 14, 2018, Hua Medicine (Shanghai)'s market cap has decreased from 8.71B to 3.00B, a decrease of -65.52%. That is a compound annual growth rate of -13.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 3.00B | -1.30% |
| Dec 31, 2025 | 3.04B | 112.44% |
| Dec 31, 2024 | 1.43B | -25.71% |
| Dec 29, 2023 | 1.93B | -46.67% |
| Dec 30, 2022 | 3.62B | -0.33% |
| Dec 31, 2021 | 3.63B | -34.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Tong Ren Tang Chinese Medicine Company | 7.39B |
| China Shineway Pharmaceutical Group | 7.33B |
| Edding Genor Group Holdings | 6.09B |
| VISEN Pharmaceuticals | 3.51B |
| Jacobson Pharma Corporation | 2.54B |
| Essex Bio-Technology | 2.51B |
| Golden Throat Holdings Group Company | 2.32B |
| JBM (Healthcare) | 2.27B |